Impact of Transepithelial Abutment Connection and Disconnection in Dental Implants
Launched by UNIVERSITY OF VALENCIA · Oct 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different methods of connecting and disconnecting dental implants affect bone health around the implants. Specifically, it looks at a technique called "one abutment, one time," which means that once the final part of the implant (the abutment) is placed during surgery, it should not be removed again until the implant has fully healed. The researchers want to see if this approach helps reduce bone loss around the implants after 12 months compared to traditional methods.
To participate in this trial, you need to be a healthy adult aged between 65 and 74, who needs at least two dental implants for crowns in the back of the mouth. Ideal candidates should have good oral health, with low levels of plaque and gum bleeding. Throughout the study, participants will undergo various evaluations, including checking for pain, bleeding, and the health of the surrounding tissues. Additionally, they will answer questions about their satisfaction with the implant process. This trial aims to gather important information that could lead to better dental implant procedures in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy partially edentulous adult patients needing at least two implants for the placement of single or consecutive crowns in the posterior mandible or maxilla will be recruited.
- • These patients should exhibit a plaque index and gingival bleeding index of less than 25%, and have sufficient bone height and width for the placement of dental implants measuring 8 or 10 mm in length and 3.5 or 4 mm in diameter.
- • Additionally, they must have at least 2 mm of keratinized vestibular gingiva, stable occlusion, and a periodontium in good health
- Exclusion Criteria:
- • Edentulous areas requiring bone grafts will be excluded.
- • Patients with medical conditions contraindicating implant surgery, such as severe bruxism or inadequate oral hygiene.
- • Pregnant or lactating women, patients undergoing bisphosphonate therapy, those receiving chemotherapy or radiotherapy in the head and neck area, non-compliant patients with incomplete data records, and those who do not attend regular follow-up appointments will also be excluded.
About University Of Valencia
The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Valencia, , Spain
Patients applied
CW
AG
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported